Literature DB >> 1670638

Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production.

G Messer1, U Spengler, M C Jung, G Honold, K Blömer, G R Pape, G Riethmüller, E H Weiss.   

Abstract

Since a dysregulated synthesis of tumor necrosis factor alpha (TNF-alpha) may be involved in the pathogenesis of autoimmune diseases, it was of interest to precisely locate the recently reported NcoI restriction fragment length polymorphism (RFLP) of the TNF-alpha region. However, by mapping of 56.8 kb of overlapping cosmid clones and direct sequencing, we could localize the polymorphic NcoI restriction site within the first intron of the TNF-beta gene and not in the TNF-alpha gene. To study whether regulatory mechanisms are affected by this polymorphism, we analyzed the TNF-alpha/TNF-beta production of phytohemagglutinin-stimulated peripheral blood mononuclear cells of individuals homozygous for the TNF-beta NcoI RFLP by ELISA and concomitant Northern blot analysis. On days 2-4 after stimulation with mitogen, the TNFB*1 allele corresponding to a 5.3-kb NcoI fragment presented with a significantly higher TNF-beta response. A mRNA analysis demonstrated that higher protein levels of TNF-beta correlate also with increased amounts of TNF-beta transcripts. No allelic association was found in respect to TNF-alpha production. To further investigate a possible allelic influence on transcription, we determined the DNA sequence of 2 kb of the 5' portion of our cloned TNFB*2 allele and compared it with the available TNF-beta sequences. By computer-aided recognition motif search of DNA binding factors, we report putative binding sites conserved between mouse and man in the 5' flanking region as well as in intron 1 of the TNF-beta gene, found also in other cytokine promoter sequences. In addition, by polymerase chain reaction amplification and sequencing of 740 bp of the 5' part of TNF-beta of individuals typed homozygously for the NcoI RFLP, we could show that amino acid position 26 is conserved as asparagine in the TNFB*1 and as threonine in the TNFB*2 sequence. A previously reported, EcoRI RFLP in the 3' untranslated region of TNF-beta does not segregate with either of the two alleles. Thus, four TNFB alleles can be defined at the DNA level.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1670638      PMCID: PMC2118757          DOI: 10.1084/jem.173.1.209

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  54 in total

1.  Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus.

Authors:  C O Jacob; Z Fronek; G D Lewis; M Koo; J A Hansen; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

2.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

3.  A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

Authors:  G Shaw; R Kamen
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

4.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

5.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

6.  Molecular cloning and expression of a receptor for human tumor necrosis factor.

Authors:  T J Schall; M Lewis; K J Koller; A Lee; G C Rice; G H Wong; T Gatanaga; G A Granger; R Lentz; H Raab
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

7.  Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor.

Authors:  H Loetscher; Y C Pan; H W Lahm; R Gentz; M Brockhaus; H Tabuchi; W Lesslauer
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

8.  Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B.

Authors:  M A Collart; P Baeuerle; P Vassalli
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  110 in total

Review 1.  Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis.

Authors:  C L Verweij
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

3.  Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin alpha genes.

Authors:  N Baxter; M Sumiya; S Cheng; H Erlich; L Regan; A Simons; J A Summerfield
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

4.  Association of a lymphotoxin alpha gene polymorphism and atopy in Italian families.

Authors:  E Trabetti; C Patuzzo; G Malerba; R Galavotti; L C Martinati; A L Boner; P F Pignatti
Journal:  J Med Genet       Date:  1999-04       Impact factor: 6.318

5.  Genetic structure of the novel low-frequency haplotype HLA-B49, SC01, DR4 and its contribution to insulin-dependent diabetes susceptibility.

Authors:  O G Segurado; P Iglesias-Casarrubios; P Morales; J Martínez-Laso; J Partanen; R D Campbell; A Arnaiz-Villena
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

6.  Mapping and genetic organization of the TNF genes in the swine Mhc.

Authors:  P Chardon; M Nunes; F Dezeure; D Andrès-Cara; M Vaiman
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

7.  Interleukin-10 (-819 C/T) and tumor necrosis factor-alpha (-308 G/A) gene variants influence gastritis and lymphoid follicle development.

Authors:  B R Achyut; Priya Tripathi; Uday Chand Ghoshal; Nikhil Moorchung; Balraj Mittal
Journal:  Dig Dis Sci       Date:  2007-08-24       Impact factor: 3.199

8.  TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction.

Authors:  Jae-Young Um; Neeon-Hyung An; Hyung-Min Kim
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

9.  Cloning and genomic characterization of LST1: a new gene in the human TNF region.

Authors:  I Holzinger; A de Baey; G Messer; G Kick; H Zwierzina; E H Weiss
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

10.  DNase I hypersensitivity mapping and promoter polymorphism analysis of human C4.

Authors:  A K Vaishnaw; R Hargreaves; R D Campbell; B J Morley; M J Walport
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.